HOME ABOUT US RESEARCH NEWS AND EVENTS INTO PRACTICE CONTACT US LINKS |
  STAY UPDATED
The latest news from the project was presented at the November 2011 RBM/UNITAID/WHO Artemisinin Conference in Hanoi and our commercial partner, East-West Seed, gave an introduction to the company. The update on the project, given by Professor Dianna Bowles, can be downloaded from this link. Information about East-West Seed presented by Bert van der Feltz, VP Sales and Marketing, can be downloaded from this link. Other presentations from the Conference can be accessed at: www.a2s2.org/index.php?id=32 To receive regular email updates, contact us at; The CNAP Artemisia Research Project is developing improved varieties of the medicinal plant Artemisia annua. This plant is the primary source of the leading anti malaria drug artemisinin. Our aim has been to use the latest genetic technologies to accelerate and enhance traditional plant breeding and create new robust, non GM varieties of Artemisia with increased artemisinin yields. CNAP and East-West Seed in partnership to improve seed supplies of vital anti-malarial plant At the Artemisinin Conference in Hanoi, the Centre for Novel Agricultural Products (CNAP) and East-West Seed announced a new partnership to ensure that seeds from improved varieties of Artemisia annua will rapidly be made available for global cultivation. This new partnership brings together an award winning research centre based in the Biology Department of the University of York and a market leader for the breeding and commercialisation of hybrid seeds throughout Asia. The partnership will help to ensure a robust supply of improved Artemisia annua seed that will contribute to the production of Artemisinin Combination Therapies for the treatment of malaria. Full details, in the press release and our new brochure, |
|
|
 |
 Department of Biology |
 |
